66530-1-Ig

antibody from Proteintech Group

Targeting: HLA-E

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

66530-1-Ig

Provider

Proteintech Group

Product name

HLA-E antibody

Antibody type

Monoclonal

Description

HLA-E antibody (Cat. #66530-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: FC, IF, IHC, WB,ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1A4G3

Vial size

20ul, 150ul

References

Submitted references

Multimodal spatial proteomic profiling in acute myeloid leukemia.

Ly CP, Veletic I, Pacheco CD, Dasdemir E, Jelloul FZ, Ferri-Borgogno S, Basi AV, Gomez JA, Root JL, Reville PK, Jindal S, Basu S, Sharma P, Quesada AE, Bueso-Ramos C, Manshouri T, Cuglievan B, Garcia M, Burks JK, Abbas HA
NPJ precision oncology 2025 May 20;9(1):148

---

Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial.

Nieto Y, Banerjee P, Kaur I, Basar R, Li Y, Daher M, Rafei H, Kerbauy LN, Kaplan M, Marin D, Griffin L, Barnett M, Bassett R, Uprety N, Shrestha R, Silva FR, Islam S, Ganesh C, Borneo Z, Ramdial J, Ramirez A, Hosing C, Alousi A, Popat U, Qazilbash M, Ahmed S, Iyer S, Sainz TP, Vega F, Fowlkes NW, Alexis K, Emig M, Harstrick A, Overesch A, Shpall EJ, Rezvani K
Nature medicine 2025 Jun;31(6):1987-1993

---

PD-1(+) NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade.

Greppi M, Tabellini G, Patrizi O, Obino V, Bozzo M, Rutigliani M, Gorlero F, Di Luca M, Paleari L, Melaiu O, Paudice M, Loiacono F, Castagnola P, Vellone VG, André P, Mavilio D, Ubezio G, Candiani S, Jandus C, Moretta L, De Censi A, Olive D, Sivori S, Vivier E, Rampinelli F, Parolini S, Pesce S, Marcenaro E
Journal of experimental & clinical cancer research : CR 2025 Aug 29;44(1):258

---

Targeting the HLA-E-NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG.

Deng Y, Liu J, Pu Z, Wang Y, Li T, Jiang Z, Xie L, Zhang X, Chen Y, Yang M, Du C, Hao S, Ji N, Zhuang Z, Feng J, Zhang L
Journal of experimental & clinical cancer research : CR 2025 Apr 29;44(1):133

---

Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD.

Pineda SS, Lee H, Ulloa-Navas MJ, Linville RM, Garcia FJ, Galani K, Engelberg-Cook E, Castanedes MC, Fitzwalter BE, Pregent LJ, Gardashli ME, DeTure M, Vera-Garcia DV, Hucke ATS, Oskarsson BE, Murray ME, Dickson DW, Heiman M, Belzil VV, Kellis M
Cell 2024 Apr 11;187(8):1971-1989.e16

---

Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance.

Liu X, Song J, Zhang H, Liu X, Zuo F, Zhao Y, Zhao Y, Yin X, Guo X, Wu X, Zhang H, Xu J, Hu J, Jing J, Ma X, Shi H
Cancer cell 2023 Feb 13;41(2):272-287.e9